can also learn useful tips for managing financial health during Covid-19 situation as well as guidelines for self-adjustment and business planning advice for SMEs after the situation improves. The
Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 HEALTH
Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Company Q3 30/09/2022 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Consolidated Q3 30/09/2022 HEALTH
but offering return to outpace increase in product and service prices; accordingly, suit the retirees having limited investment knowledge or favoring financial experts to manage their money. In Thailand
Derivative Warrants | ALIHEA41C2304A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN APRIL 2023 # A
Derivative Warrants | ALIHEA41C2304B | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN APRIL 2023 # B
Derivative Warrants | ALIHEA28C2304A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN APRIL 2023 # A
Derivative Warrants | ALIHEA28C2402A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN FEBRUARY 2024
Derivative Warrants | ALIHEA41C2310A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN OCTOBER 2023
Derivative Warrants | ALIHEA28C2308A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN AUGUST 2023